Thank you, Phil. First, as usual, I want to remind everyone that any forward-looking information that we discuss today is being provided in accordance with the provisions of the Private Securities Litigation Reform Act of 1995. We have made reasonable efforts to ensure that the information, assumptions and beliefs upon which this forward-looking information is based are current, reasonable and complete. However, a variety of factors could cause actual results to differ materially from those anticipated in any forward-looking information. A description of those factors is set forth in the company's SEC filings. Accordingly, there can be no assurance that the forward-looking information discussed today will occur or that our objectives will be achieved. We assume no obligation to publicly update or revise any forward-looking statements made today or any other forward-looking statements made by the company, whether as a result of new information, future events or otherwise. Now for the financial results. As you all know, we preannounced disappointing results for the third quarter via a press release on March 14, followed by a conference call on March 15. So the full results that we reported yesterday are consistent with that earlier announcement. For the third quarter, we reported an adjusted net loss attributable to shareholders of $0.01 per diluted share on revenues of $151 million. That reflects a total revenue growth rate of 11% for the quarter and an organic revenue growth rate of 8% for the quarter. The adjusted loss excludes a $600,000 pretax, nonroutine charge associated with the Venezuelan currency devaluation that was announced by its government in February this year. Including this nonroutine charge, our GAAP loss for the quarter was $0.03 per share. In spite of the disappointing results for the third quarter, however, we remain on pace for another record year. For the year-to-date period, revenues were $513 million, up 18% over last year, and adjusted earnings were $1.01 per diluted share compared to adjusted earnings last year of $0.95 per diluted share. Now with respect to some cash flow and other financial-related items. Capital expenditures for the quarter were $6 million, depreciation and amortization was $4.8 million and noncash compensation was $900,000. Adjusted EBITDA for the quarter was $6.3 million and $84 million on a trailing 12-month basis. At February 28, our total debt was $89 million, cash was $36 million, and thus, net debt was $53 million. So our net debt to trailing 12-month EBITDA was 0.6:1. And with that, I'll turn it over now to Pete who will provide a little more color about our third quarter revenues and business.